BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Montalto M, Gallo A, Curigliano V, D’Onofrio F, Santoro L, Covino M, Dalvai S, Gasbarrini A, Gasbarrini G. Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study. Aliment Pharmacol Ther. 2010;32:209-214. [PMID: 20384610 DOI: 10.1111/j.1365-2036.2010.04324.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Rekatsina M, Paladini A, Cifone MG, Lombardi F, Pergolizzi JV, Varrassi G. Influence of Microbiota on NSAID Enteropathy: A Systematic Review of Current Knowledge and the Role of Probiotics. Adv Ther 2020;37:1933-45. [PMID: 32291647 DOI: 10.1007/s12325-020-01338-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
2 Tai FWD, McAlindon ME. NSAIDs and the small bowel. Curr Opin Gastroenterol 2018;34:175-82. [PMID: 29438118 DOI: 10.1097/MOG.0000000000000427] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 18.0] [Reference Citation Analysis]
3 Park AM, Khadka S, Sato F, Omura S, Fujita M, Hsu DK, Liu FT, Tsunoda I. Galectin-3 as a Therapeutic Target for NSAID-Induced Intestinal Ulcers. Front Immunol 2020;11:550366. [PMID: 33072090 DOI: 10.3389/fimmu.2020.550366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Edogawa S, Peters SA, Jenkins GD, Gurunathan SV, Sundt WJ, Johnson S, Lennon RJ, Dyer RB, Camilleri M, Kashyap PC, Farrugia G, Chen J, Singh RJ, Grover M. Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota. FASEB J 2018;:fj201800560R. [PMID: 29897814 DOI: 10.1096/fj.201800560R] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
5 Sharma S, Chaturvedi J, Chaudhari BP, Singh RL, Kakkar P. Probiotic Enterococcus lactis IITRHR1 protects against acetaminophen-induced hepatotoxicity. Nutrition 2012;28:173-81. [DOI: 10.1016/j.nut.2011.02.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
6 Montalto M, Gallo A, Gasbarrini A, Landolfi R. NSAID enteropathy: could probiotics prevent it? J Gastroenterol. 2013;48:689-697. [PMID: 22875474 DOI: 10.1007/s00535-012-0648-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
7 Singh DP, Borse SP, Nivsarkar M. Clinical importance of nonsteroidal anti-inflammatory drug enteropathy: the relevance of tumor necrosis factor as a promising target. Transl Res 2016;175:76-91. [PMID: 27083387 DOI: 10.1016/j.trsl.2016.03.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
8 Marlicz W, Loniewski I, Grimes DS, Quigley EM. Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: Contrasting interactions in the stomach and small intestine. Mayo Clin Proc. 2014;89:1699-1709. [PMID: 25440891 DOI: 10.1016/j.mayocp.2014.07.015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
9 Fornai M, Pellegrini C, Benvenuti L, Tirotta E, Gentile D, Natale G, Ryskalin L, Colucci R, Piccoli E, Ghelardi E, Blandizzi C, Antonioli L. Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy. Nutrition 2020;70:110583. [PMID: 31739175 DOI: 10.1016/j.nut.2019.110583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Lué A, Lanas A. Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits. World J Gastroenterol 2016;22:10477-81. [PMID: 28082800 DOI: 10.3748/wjg.v22.i48.10477] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
11 Saul S, Fuessel J, Runde J. Pediatric Digestive Health and the Gut Microbiome: Existing Therapies and a Look to the Future. Pediatr Ann 2021;50:e336-42. [PMID: 34398717 DOI: 10.3928/19382359-20210720-01] [Reference Citation Analysis]
12 Otani K, Tanigawa T, Watanabe T, Shimada S, Nadatani Y, Nagami Y, Tanaka F, Kamata N, Yamagami H, Shiba M, Tominaga K, Fujiwara Y, Arakawa T. Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage. Digestion 2017;95:22-8. [DOI: 10.1159/000452356] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 12.8] [Reference Citation Analysis]
13 Utzeri E, Usai P. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. World J Gastroenterol. 2017;23:3954-3963. [PMID: 28652650 DOI: 10.3748/wjg.v23.i22.3954] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
14 Bures J, Smajs D, Kvetina J, Förstl M, Smarda J, Kohoutova D, Kunes M, Cyrany J, Tacheci I, Rejchrt S, Lesna J, Vorisek V, Kopacova M. Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle. World J Gastroenterol 2011;17:609-17. [PMID: 21350709 DOI: 10.3748/wjg.v17.i5.609] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
15 Grattagliano I, Ubaldi E, Portincasa P. Drug-induced enterocolitis: Prevention and management in primary care. J Dig Dis. 2018;19:127-135. [PMID: 29417737 DOI: 10.1111/1751-2980.12585] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
16 Endo H, Sakai E, Kato T, Umezawa S, Higurashi T, Ohkubo H, Nakajima A. Small bowel injury in low-dose aspirin users. J Gastroenterol 2015;50:378-86. [PMID: 25501289 DOI: 10.1007/s00535-014-1028-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
17 Lyra A, Saarinen M, Putaala H, Olli K, Lahtinen SJ, Ouwehand AC, Madetoja M, Tiihonen K. Bifidobacterium animalis ssp. lactis 420 Protects against Indomethacin-Induced Gastric Permeability in Rats. Gastroenterol Res Pract 2012;2012:615051. [PMID: 22848210 DOI: 10.1155/2012/615051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Endo H, Higurashi T, Hosono K, Sakai E, Sekino Y, Iida H, Sakamoto Y, Koide T, Takahashi H, Yoneda M. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol. 2011;46:894-905. [PMID: 21556830 DOI: 10.1007/s00535-011-0410-1] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
19 Lim YJ, Chun HJ. Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges. Gastroenterol Res Pract 2013;2013:761060. [PMID: 24159330 DOI: 10.1155/2013/761060] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
20 Li Z, Wang Z, Shen B, Chen C, Ding X, Song H. Effects of aspirin on the gastrointestinal tract: Pros vs. cons. Oncol Lett 2020;20:2567-78. [PMID: 32782574 DOI: 10.3892/ol.2020.11817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 García-rayado G, Navarro M, Lanas A. NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs. Expert Review of Clinical Pharmacology 2018;11:1031-43. [DOI: 10.1080/17512433.2018.1516143] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 8.7] [Reference Citation Analysis]
22 Byun S, Lim T, Lim Y, Seo J, Chung M. In vivo effects of s-pantoprazole, polaprenzinc, and probiotic blend on chronic small intestinal injury induced by indomethacin. Beneficial Microbes 2016;7:731-7. [DOI: 10.3920/bm2016.0029] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mäkelä SM, Forssten SD, Kailajärvi M, Langén VL, Scheinin M, Tiihonen K, Ouwehand AC. Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti-inflammatory drug: A randomized, placebo-controlled, double-blind clinical trial. Br J Clin Pharmacol 2021. [PMID: 33908058 DOI: 10.1111/bcp.14880] [Reference Citation Analysis]
24 Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol 2016;22:7186-202. [PMID: 27621567 DOI: 10.3748/wjg.v22.i32.7186] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
25 Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A. Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs. Gastroenterology. 2018;154:500-514. [PMID: 29221664 DOI: 10.1053/j.gastro.2017.10.049] [Cited by in Crossref: 167] [Cited by in F6Publishing: 120] [Article Influence: 41.8] [Reference Citation Analysis]
26 Maseda D, Ricciotti E. NSAID-Gut Microbiota Interactions. Front Pharmacol. 2020;11:1153. [PMID: 32848762 DOI: 10.3389/fphar.2020.01153] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
27 Syer SD, Wallace JL. Environmental and NSAID-enteropathy: dysbiosis as a common factor. Curr Gastroenterol Rep 2014;16:377. [PMID: 24532193 DOI: 10.1007/s11894-014-0377-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
28 Jiménez-serna A, Hernández-sánchez H. Effect of Different Antibiotics and Non-Steroidal Anti-Inflammatory Drugs on the Growth of Lactobacillus casei Shirota. Curr Microbiol 2011;62:1028-33. [DOI: 10.1007/s00284-010-9819-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Bielsa-fernández M, Tamayo-de la Cuesta J, Lizárraga-lópez J, Remes-troche J, Carmona-sánchez R, Aldana-ledesma J, Avendaño-reyes J, Ballesteros-amozorrutia M, De Ariño M, de Giau-triulzi L, Flores-rendón R, Huerta-guerrero H, González-gonzález J, Hernández-guerrero A, Murcio-pérez E, Jáquez-quintana J, Meixueiro-daza A, Nogueira-de Rojas J, Rodríguez-hernández H, Santoyo-valenzuela R, Solorzano-olmos S, Uscanga-domínguez L, Zamarripa-dorsey F. Consenso mexicano sobre diagnóstico, prevención y tratamiento de la gastropatía y enteropatía por antiinflamatorios no esteroideos. Revista de Gastroenterología de México 2020;85:190-206. [DOI: 10.1016/j.rgmx.2019.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wang X, Tang Q, Hou H, Zhang W, Li M, Chen D, Gu Y, Wang B, Hou J, Liu Y, Cao H. Gut Microbiota in NSAID Enteropathy: New Insights From Inside. Front Cell Infect Microbiol 2021;11:679396. [PMID: 34295835 DOI: 10.3389/fcimb.2021.679396] [Reference Citation Analysis]
31 Chan FK. NSAID-Associated Lower Gastrointestinal Bleeding: Where Do We Stand? Clinical Gastroenterology and Hepatology 2012;10:1060-1. [DOI: 10.1016/j.cgh.2012.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
32 Guo CG, Leung WK. Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract. Gut Liver 2020;14:179-89. [PMID: 31547642 DOI: 10.5009/gnl19201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
33 Watanabe T, Fujiwara Y, Chan FKL. Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review. J Gastroenterol 2020;55:481-95. [PMID: 31865463 DOI: 10.1007/s00535-019-01657-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
34 Scarpignato C, Hunt RH. Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. Gastroenterol Clin North Am. 2010;39:433-464. [PMID: 20951911 DOI: 10.1016/j.gtc.2010.08.010] [Cited by in Crossref: 148] [Cited by in F6Publishing: 124] [Article Influence: 14.8] [Reference Citation Analysis]
35 Shin SJ, Noh CK, Lim SG, Lee KM, Lee KJ. Non-steroidal anti-inflammatory drug-induced enteropathy. Intest Res 2017;15:446-55. [PMID: 29142512 DOI: 10.5217/ir.2017.15.4.446] [Cited by in Crossref: 43] [Cited by in F6Publishing: 26] [Article Influence: 10.8] [Reference Citation Analysis]
36 Koretz RL. Probiotics in Gastroenterology: How Pro Is the Evidence in Adults? Am J Gastroenterol 2018;113:1125-36. [PMID: 29915396 DOI: 10.1038/s41395-018-0138-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
37 Gwee KA, Goh V, Lima G, Setia S. Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: Risks versus benefits. J Pain Res. 2018;11:361-374. [PMID: 29491719 DOI: 10.2147/jpr.s156938] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 8.3] [Reference Citation Analysis]
38 Bures J, Pejchal J, Kvetina J, Tichý A, Rejchrt S, Kunes M, Kopacova M. Morphometric analysis of the porcine gastrointestinal tract in a 10-day high-dose indomethacin administration with or without probiotic bacteria Escherichia coli Nissle 1917. Hum Exp Toxicol 2011;30:1955-62. [PMID: 21441285 DOI: 10.1177/0960327111403174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
39 Syer SD, Blackler RW, Martin R, de Palma G, Rossi L, Verdu E, Bercik P, Surette MG, Aucouturier A, Langella P, Wallace JL. NSAID enteropathy and bacteria: A complicated relationship. J Gastroenterol. 2015;50:387-393. [PMID: 25572030 DOI: 10.1007/s00535-014-1032-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
40 Guslandi M. Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents. World J Gastroenterol 2012;18:4241-2. [PMID: 22919262 DOI: 10.3748/wjg.v18.i31.4241] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
41 Wallace JL. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol. 2013;19:1861-1876. [PMID: 23569332 DOI: 10.3748/wjg.v19.i12.1861] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 86] [Article Influence: 14.9] [Reference Citation Analysis]
42 Elangovan A, Allegretti JR, Fischer M. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation. Expert Opin Biol Ther 2019;19:1343-55. [PMID: 31570017 DOI: 10.1080/14712598.2019.1673725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 McEvoy L, Carr DF, Pirmohamed M. Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity. Front Pharmacol 2021;12:684162. [PMID: 34234675 DOI: 10.3389/fphar.2021.684162] [Reference Citation Analysis]